Statistics
We looked inside some of the posts by decentralvaccine and here's what we found interesting.
Average Info
Notes Per Post
0
Likes Per Post
0
Reblog Per Post
0
Reply Per Post
0
Time Between Posts
16 hours
Number of Posts By Type
Text
17
Last Seen Tumblr Blogs
Fun Fact
In Q3 of 2020, 31% of US users access the Tumblr app daily.
Text
US Vaccine Experts Fear Other Vaccines Might Be Banned
As top US health officials turn against some mRNA vaccines, experts fear for the country’s preparedness for the next pandemic and worry that other vaccines will be targeted next.
Donald Trump’s administration recently canceled a $766m award to Moderna on the research and development of H5N1 bird flu vaccines, and officials have announced new restrictions and regulations for Covid mRNA vaccines – actions that signal a move away from the breakthrough technology.
0 notes
Text
Ousted CDC Members Fear That Scientific Expertise Is No Longer Valued
Helen Chu went through a multiyear process to finally gain a seat on the Centers for Disease Control and Prevention’s vaccines experts panel, the Advisory Committee on Immunization Practices. There was a lengthy application process, and extensive conflict-of-interest vetting, followed by training about how the committee conducts its operations.
Chu, a professor of infectious diseases at the University of Washington, was appointed last year to a four-year term on the committee. She participated in one meeting as a voting member. And then she and the rest of her colleagues on the ACIP were summarily terminated on Monday, in a move health secretary Robert F. Kennedy Jr. — an avowed vaccine skeptic and longtime ACIP critic — insisted was necessary to restore public confidence in vaccines.
0 notes
Text
Vaccine Expert Fearful Of New CDC Vaccine Advisors
It’s been another tumultuous week for vaccines and public health. Health secretary Robert F. Kennedy Jr. fired all 17 members of an expert panel that advises the Centers for Disease Control and Prevention on immunizations.
Kennedy, as everyone’s aware, is openly skeptical of vaccines. He said he took the extraordinary step to “restore public trust in vaccines.” He accused the advisory group of “malevolent malpractice” for acting as a “rubber stamp” for vaccine approvals without adequate safety data. The current experts were riddled with conflicts of interest, Kennedy claimed.
https://www.statnews.com/2025/06/13/vaccine-expert-very-worried-hhs-secretary-kennedy-replaces-acip-members/
0 notes
Text
Kennedy Hires 8 Vaccine Experts After Firing 17
Health and Human Services Secretary Robert F. Kennedy Jr. announced Wednesday that he has selected eight new people to join the national vaccine panel after firing all 17 of its members.
In an X post, Kennedy revealed that he "took a major step towards restoring public trust in vaccines" on Monday by reconstituting the Advisory Committee for Immunization Practices (ACIP).
"I retired the 17 current members of the committee. I’m now repopulating ACIP with the eight new members who will attend ACIP’s scheduled June 25 meeting," Kennedy wrote on Wednesday. "The slate includes highly credentialed scientists, leading public-health experts, and some of America’s most accomplished physicians. All of these individuals are committed to evidence-based medicine, gold-standard science, and common sense."
0 notes
Text
Covid 19 Vaccines Could Now Cost $150
If you're planning on getting a Covid-19 booster this fall, you could be faced with a hefty bill — even if you have insurance.
Health and Human Services Secretary Robert F. Kennedy Jr. announced in May that the Centers for Disease Control and Prevention no longer recommends a Covid-19 vaccine for healthy children and pregnant people.
https://www.cnbc.com/amp/2025/06/11/a-covid-vaccine-could-soon-cost-as-much-as-150even-if-youre-insured.html
0 notes
Text
BioNTech Buys CureVac Valued At $1.25B
BioNTech is buying fellow German mRNA vaccine developer CureVac in an all-stock transaction that values the acquired biotech at $1.25 billion.
The announcement makes no specific mention of onboarding any of CureVac’s wholly-owned candidates, which are led by a phase 1-stage therapeutic mRNA vaccine for resected glioblastoma. Instead, BioNTech singled out CureVac’s “state-of-the-art” research and manufacturing site in Tübingen, Germany as a major prize.
0 notes
Text
Ideas For A CDC Alternative
The medical establishment has floated ideas such as state-appointed boards or medical specialty associations serving as clearinghouses for information on vaccine safety and efficacy for clinicians.
California Gov. Gavin Newsom (D) during the pandemic created a state entity to review the safety of federally approved COVID-19 vaccines before distributing them to the public.
But it would be difficult to replicate the professional clout of ACIP, whose recommendations can influence whether insurers cover vaccines.
That would leave Kennedy's handpicked successors controlling the narrative — a prospect many researchers and physicians think will bring a radical departure from ACIP's evidence-based deliberations on safety and efficacy.
https://www.axios.com/2025/06/11/vaccines-public-health-apic-cdc-rfk
0 notes
Text
Concerns Rise Over Access To Covid 19 Vaccines
Some healthy pregnant women, parents of healthy kids and younger healthy adults are worried they won't be able to get vaccinated against COVID-19 because of the recent changes in access by the federal government.
0 notes
Text
Trump Terminated A Promising HIV Vaccine Program
For nearly 15 years, Dennis Burton worked on a project aimed at solving what he calls "one of the most difficult problems in biomedicine" — creating an HIV vaccine.
That work was funded by the largest National Institutes of Health-funded program devoted to such research, with a seven-year grant totaling $258 million, and is considered one of the leading vaccine efforts. On May 30, he learned that work will end. In a video call, NIH officials told him that the Trump administration was terminating the program next year.
"It's just devastating. So much human toil has gone into this," says the Scripps Research Institute immunologist. "Just when it looked like we could beat this virus, we're going to give up.
0 notes
Text
Novel Polio Vaccine Matches Traditional Vaccine Immune Response
The novel oral polio vaccine type 2 (nOPV2) induced intestinal mucosal immune responses comparable to those induced by the traditional Sabin monovalent oral polio vaccine type 2 (mOPV2) across different age groups, with the strongest responses observed in infants.
0 notes
Text
Concerns Over Spike Proteins May Have Impeded US Further Support For The Development Of mRNA Vaccines
There needs to be an established database of vaccine injuries that can be accurately quantified with full transparency, without politics or big money pressure influencing the data,” he added. “There’s a growing body of peer-reviewed studies that indicate the spike proteins are causing havoc in certain recipients.”
The IMA, previously known as Front Line COVID-19 Critical Care Alliance, launched a campaign in support of Kennedy’s nomination to be HHS secretary. The group drew controversy when its founders promoted ivermectin as a “miracle drug” for COVID-19.
Myocarditis, or inflammation of the heart muscle, is of particular concern among mRNA vaccine opponents. An analysis published in 2022 found that myocarditis occurred in about 31.2 cases per 1 million second doses of the Moderna COVID-19 vaccine, or 0.003 percent.
Rates of myocarditis are significantly higher among people with COVID-19 infections than immunizations, however.
The development of the COVID-19 mRNA vaccine was aided by the Trump administration’s Operation Warp Speed, something Trump has boasted about at numerous points.
0 notes
Text
Vaccine Manufacturers Stocks Remain Steady Despite The Firing Of All CDC Vaccine Advisors
The muted stock reaction may be due to the lead-up to the announcement. RFK Jr’s is widely known to be a vaccine skeptic, and related stocks have already taken a serious hit in the past year.
Moderna is down 80% in the last 12 months, Merck has fallen 40%, and Pfizer has dropped 14%. Merck and Pfizer are now trading at a forward price to earnings ratio of 8.6 and 7.9, respectively. Moderna has been making a loss in six out of the eight last quarters.
The overhaul to CDC’s Advisory Committee on Immunization Practices (ACIP) is a risk to vaccine manufacturers, Leerink analysts led by Daina Graybosch said. “At best, it will take time for the new members to ramp up on the content and ACIP process,” she said. “At worst, the committee could upend current recommendations for novel and existing vaccines.”
https://www.barrons.com/articles/pfizer-stock-moderna-merck-rfk-jr-vaccine-53bbe8d8
0 notes
Text
A 75% Immune Response For A Breakthrough Breast Cancer Vaccine
The most common cancer in women — and one of the deadliest — may have finally met its match.
Development of a breakthrough vaccine researchers say could eradicate breast cancer wrapped up its phase one clinical trial this week, with more than 75% of women showing a strong immune response, as measured by antibodies on their white blood cells.
The vaccine is aimed at both preventing and treating breast cancer — which affects one in eight women.
0 notes
Text
The Nipah Virus Vaccine May Soon Become Available For Patients
A vaccine for the deadly Nipah virus, developed by the University of Oxford, may soon be available to patients.
The vaccine has been granted support from the European Medicines Agency's Prime scheme to fast-track treatment delivery.
The World Health Organisation considers Nipah a research priority due to its pandemic potential and high fatality rate (up to 85%).
Nipah can transmit to humans via animals, contaminated foods, or directly from person to person, causing symptoms like fever and potentially fatal brain swelling.
The University of Oxford is currently conducting phase 1 testing of its Nipah jab after promising early results, with the EMA noting the increasing risk of Nipah virus transmission due to human encounters with fruit bats.
0 notes
Text
The Positions Of Four Members Of CDCs Expert Panel On Vaccines Has Been Terminated
Four members of the 19-person expert panel that advises the Centers for Disease Control and Prevention on vaccination policy have been informed that their status as special government employees has been terminated — a development that throws into question their ability to continue to work on the body, STAT has learned.
The Advisory Committee on Immunization Practices has been in the crosshairs of health secretary Robert F. Kennedy Jr., who recently pre-empted the group’s plan to revise guidance on use of Covid-19 vaccines at its next scheduled meeting in late June by issuing his own recommendations — which was unprecedented.
0 notes
Text
A Rise In Needless Deaths Due To Vaccine Hesitancy
Measles, pertussis, influenza. Not long ago, incidence of these and other childhood diseases had been dramatically reduced, thanks to vaccines — with measles virtually eradicated in the United States. Now, cases of measles and pertussis (whooping cough) are surging and childhood flu deaths have risen.
While several factors contribute to the spread of diseases, Paul Offit, MD, one of the nation’s premier infectious disease experts, sees a common culprit in the latest trends: the spread of misinformation about the risks of vaccines, fueling a rise in vaccine hesitancy. As a result, more Americans are declining vaccines for their children as well as for themselves.
“Our children are suffering needlessly,” says Offit, a professor of vaccinology and of pediatrics at the Perelman School of Medicine at the University of Pennsylvania, and a member of the Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee.
0 notes
Text
Federal Government Declines Extending Grant For HIV/AIDs Vaccine Development
The US Department of Health and Human Services will not extend a grant funding the Center for HIV/AIDS Vaccine Development, work that was led in part by Duke Health.
"Without funding, the major thing that we're doing is slowing innovation, slowing the opportunities of being able to get rid of this disease," said Veleria Levy, Executive Director of the North Carolina AIDS Action Network.
"I'm unfortunately not surprised. I think this is the beginning of some really deep cuts in the HIV space. Some deep and dangerous cuts. As we are finally getting to see a glimmer of light at the end of the tunnel and now is not the time to take our foot off the gas," added Chelsea Gulden, the Chief Executive Officer of RAIN Inc.
0 notes